Related Experiment Video
Updated: Jul 20, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient
Hernán Trimarchi1, Fernando Lombi, Mariano Forrester
1Department of Medicine, Hospital Británico de Buenos Aires, Argentina. htrimarchi@hotmail.com
Background:
A 48-year-old man with a recent diagnosis of multiple myeloma and rapidly progressive oliguric end-stage renal disease requiring hemodialysis, presented with a serum calcium concentration of 3.4 mmol/l (13.6 mg/dl).
Investigations:
Serum laboratory analysis, electroencephalogram, MRI of the brain and bone marrow, and kidney biopsies.
Diagnosis:
Hypercalcemia secondary to multiple myeloma.
Management:
Short-term intravenous disodium pamidronate therapy (30 mg daily) and daily monitoring of serum calcium concentration.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Hemodialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure